"It's good to know": Experiences of gene identification and result disclosure in familial epilepsies

Epilepsy Research

Volumn 112, Issue , 2015, Pages 64-71

  Vears, Danya F ^a   Dunn, Karen L ^a   Wake, Samantha A ^a,b   Scheffer, Ingrid E ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Epilepsy; Genetic counselling; Genetic testing; Genetics; Qualitative research

Indexed keywords

ADULT; AGED; ALTRUISM; ARTICLE; AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY; CLINICAL ARTICLE; DISEASE SEVERITY; EPILEPSY; FAMILIAL DISEASE; FAMILY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; CLINICAL DECISION MAKING; DAILY LIFE ACTIVITY; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MUTATION; PSYCHOLOGY;

4 AMINOBUTYRIC ACID A RECEPTOR; GABRG2 PROTEIN, HUMAN; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA4 SUBUNIT; NICOTINIC RECEPTOR; SCN1B PROTEIN, HUMAN; VOLTAGE GATED SODIUM CHANNEL BETA 1 SUBUNIT;

ACTIVITIES OF DAILY LIVING; CLINICAL DECISION-MAKING; DISCLOSURE; EPILEPSY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MUTATION; RECEPTORS, GABA-A; RECEPTORS, NICOTINIC; VOLTAGE-GATED SODIUM CHANNEL BETA-1 SUBUNIT;

EID: 84926304342     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2015.02.011     Document Type: Article

References (47)

1. Bakos A.D., Hutson S.P., Loud J.T., Peters J.A., Giusti R.M., Greene M.H. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Health Expect. 2008, 11(3):220-231.
2. Braun V., Clarke V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006, 3:77-101.
3. Chapman E. Ethical dilemmas in testing for late onset conditions: reactions to testing and perceived impact on other family members. J. Genet. Couns. 2002, 11(5):351-367.
4. Dorval M., Patenaude A.F., Schneider K.A., Kieffer S.A., DiGianni L., Kalkbrenner K.J., et al. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J. Clin. Oncol. 2000, 18(10):2135-2142.
5. Elliott I.M., Lach L., Smith M.L. I just want to be normal: a qualitative study exploring how children and adolescents view the impact of intractable epilepsy on their quality of life. Epilepsy Behav. 2005, 7:664-678.
6. Etchegary H., Fowler K. 'They had the right to know.' Genetic risk and perceptions of responsibility. Psychol. Health 2008, 23(6):707-727.
7. Fanos J.H. Developmental tasks of childhood and adolescence: implications for genetic testing. Am. J. Hum. Genet. 1997, 71:22-28.
8. Fisher R.S. Epilepsy from the patient's perspective: review of results of a community-based survey. Epilepsy Behav. 2000, 1(4):S9-S14.
9. Forrest L.E., Curnow L., Delatycki M.B., Skene L., Aitken M. Health first, genetics second: exploring families' experiences of communicating genetic information. Eur. J. Hum. Genet. 2008, 16:1329-1335.
10. Geller G., Doksum T., Bernhardt B., Metz S. Participation in breast cancer susceptibility protocols: influence of recruitment source, altruism, and family involvment on women's decisions. Cancer Epidemiol. Biomark. Prev. 1999, 8(4):377.
11. Haddow G. We only did it because he asked us: gendered accounts of participation in a population genetic data collection. Soc. Sci. Med. 2009, 69:1010-1017.
12. Half E., Bercovich D., Rozen P. Familial adenomatous polyposis. Orphanet J. Rare Dis. 2009, 4.
13. Hallowell N., Foster C., Eeles R., Ardern-Jones A., Murday V., Watson M. Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. J. Med. Ethics 2003, 29:74-83.
14. Helbig K.L., Bernhardt B.A., Conway L.J., Valverde K.D., Helbig I., Sperling M.R. Genetic risk perception and reproductive decision making among people with epilepsy. Epilepsia 2010, (E-pub).
15. Kreiger N., Ashbury F., Cotterchio M., Macey J. A qualitative study of subject recruitment for familial cancer research. Ann. Epidemiol. 2001, 11(4):219-224.
16. Lafayette D., Abuelo D., Passero M.A., Tantravahi U. Attitudes toward cystic fibrosis carrier and prenatal testing and utilization of carrier testing among relatives of individuals with cystic fibrosis. J. Genet. Couns. 1999, 8(1):17-36.
17. Liamputtong P., Ezzy D. Qualitative Research Methods 2005, Oxford University Press, New York.
18. Lim J., Macluran M., Price M., Bennett B., Butow P. Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. J. Genet. Couns. 2004, 13(2):115-133.
19. Marini C., Harkin L.A., Wallace R.H., Mulley J.C., Scheffer I.E., Berkovic S.F. Childhood absence epilepsy and febrile seizures: a family with a GABAa receptor protein. Brain 2003, 126:230-240.
20. Marteau T.M., Croyle R.T. The new genetics. Psychological responses to genetic testing. Br. Med. J. 1998, 316(7132):693-696.
21. Massie J., Curnow L., Gaffney L., Carlin J., Francis I. Declining prevalence of cystic fibrosis since the introduction of newborn screening. Arch. Dis. Child. 2010, 95(7):531-533.
22. McCann S., MacAuley D., Barnett Y., Bunting B., Bradley A., Jeffers L., et al. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psycho-Oncology 2009, (January). (E-publication).
23. Meiser B., Collins V., Warren R., Gaff C., St John D.J., Young M.A., et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin. Genet. 2004, 66(6):502-511.
24. Metcalfe A., Coad J., Plumridge G.M., Gill P., Farndon P. Family communication between children and their parents about inherited condition: a meta-synthesis of the research. Eur. J. Hum. Genet. 2008, 16:1193-1200.
25. Namey E.E., Beskow L.M. Epilepsy patient-participants and genetic research results as answers. J. Empir. Res. Hum. Res. Ethics 2011, 6(4):21-29.
26. Okeke J.O., Tangel V.E., Sorge S.T., Hesdorffer D.C., Winawer M.R., Goldsmith J., et al. Genetic testing preferences in families containing multiple individuals with epilepsy. Epilepsia 2014, (Epub ahead of print, 29 September).
27. Ottman R., Hirose S., Jain S., Lerche H., Lopes-Cendes I., Noebels J.L., et al. Genetic testing in the epilepsies. Report of the ILAE genetics commission. Epilepsia 2010, 51(4):655-670.
28. Palmer S.C., Kagee A., Kruus L., Coyne J.C. Overemphasis of psychological risks of genetic testing may have dire consequences. Psychosomatics 2002, 43(1):86-87. (author reply 87-88).
29. Parker H., Qureshi N., Ulph F., Kai J. Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges. BMC Health Serv. Res. 2007, 7:203.
30. Pinikanana J., Dono J. The lived experience of initial symptoms of and factors triggering epileptic seizures. Epilepsy Behav. 2009, 15:513-520.
31. Ponder M., Statham H., Hallowell N., Moon J.A., Richards M., Raymond F.L. Genetic research on rare familial disorders: consent and the blurred boundaries between clinical service and research. J. Med. Ethics 2008, 34(9):690-694.
32. Reed K. Antenatal screening and the gendering of genetic responsibility. Reprod. Health 2007, 4:8.
33. Rhodes P.J., Small N.A., Ismail H., Wright J.P. 'What really annoys me is people take it like it's a disability', epilepsy. disability and identify among people of Pakistani origin living in the UK. Ethn. Health 2008, 13(1):1-21.
34. Richards L. Data alive! The thinking behind NVivo. Qual. Health Res. 1999, 9(3):412-428.
35. Rogowski W.H., Grosse S.D., Khoury M.J. Science and society: challenges of translating genetic tests into clinical and public health practice. Nat. Rev. Genet. 2009, 10(7):489-495.
36. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., Fish D.R., Marsden C.D., Andermann E., et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain 1995, 118:61-73.
37. Scheffer I.E., Harkin L.A., Grinton B.E., Dibbens L.M., Turner S.J., Zielinski M.A., et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007, 130(Pt 1):100-109.
38. Schneider J.W., Conrad P. In the closet with illness: epilepsy, stigma potential and information control. Soc. Probl. 1980, 28(1):32-44.
39. Shostak S., Zarhin D., Ottman R. What's at stake? Genetic information from the perspective of people with epilepsy and their family members. Soc. Sci. Med. 2011, 73:645-654.
40. Smith C.O., Lipe H.P., Bird T.D. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch. Neurol. 2004, 61(6):875-880.
41. Smith D.F., Baker G.A., Dewey M., Jacoby A., Chadwick D.W. Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy. Epilepsy Res. 1991, 9(3):231-241.
42. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 1995, 11(2):201-203.
43. Twomey J.G., Bove C., Cassidy D. Presymptomatic genetic testing in children for neurofibromatosis 2. J. Pediatr. Nurs. 2008, 23(3):183-194.
44. Van Riper M. Genetic testing and the family. J. Midwifery Womens Health 2005, 50(3):227-233.
45. Velissaris S.L., Wilson S.J., Saling M.M., Newton M.R., Berkovic S.F. The psychological impact of a newly diagnosed seizure: losing and restoring perceived control. Epilepsy Behav. 2007, 10:223-233.
46. Wallace R.H., Marini C., Petrou S., Harkin L.A., Bowser D.N., Panchal R.G., et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 2001, 28(1):49-52.
47. Weitzel J.N., Blazer K.R., MacDonald D.J., Culver J.O., Offit K. Genetics, genomics, and cancer risk assessment state of the art and future directions in the era of personalized medicine. CA - Cancer J. Clin. 2011, 61(5):327-359.